NetraAI decodes the complexities of patient populations, offering invaluable insights to clinical trial professionals. It enhance the efficiency and reliability of clinical trials. To achieve this, it harnesses the power of cutting-edge Attractor-based technology, capable of discerning the unique combinations of variables that define patient characteristics.

Netra Placebo

NetraPlacebo pinpoints the patients in your trial who are eliciting the placebo response, and the reasons why. By combining attitudinal and psychological data, alongside information from previous trials, NetraPlacebo constructs a model that identifies the factors propelling both the placebo and drug response, enabling optimal trial enrichment allowing inclusion/exclusion criteria adjustments without adversely affecting your drug’s response and maximizing separation

Netra GPT

NetraGPT adds additional explainability to NetraAI’s Attractor-based technology, augmenting these signals with the robust abilities of Large Language Models. The multidimensional patient profiling is further enhanced through the perspective of extensive medical and scientific literature.

Meet The Founder

Dr Joseph Geraci, Ph.D. is a mathematician, medical scientist, and quantum machine learning specialist. He holds postdocs in artificial intelligence, oncology, and neuropsychiatry. He has developed novel machine intelligence algorithms that are capable of providing extraordinary insights into small complex data sets, like those found in clinical trials.

He is associated with the department of Molecular Medicine and Pathology at Queen’s University in Ontario, Canada and the Centre for Biotechnology and Genomics Medicine Medical College of Georgia, USA, and is a visiting scientist in quantum computation and neuroscience at the University of California, San Diego.

LEARN MORE